Skip to main content Skip to search Skip to main navigation
 Get a free Melatonin Spray with purchases over €100  Get a free Melatonin Spray with purchases over €100 X
Menu
Premium Nahrungsergänzungsmittel | artgerecht

Inclisiran: Mechanism, Dosage & Side Effects

Inclisiran is an innovative medication used to lower LDL cholesterol levels. It is administered by injection just twice a year and belongs to the class of siRNA therapeutics.

Regular tips about health Regular tips about health
Lexicon Navigation

Things worth knowing about "Inclisiran"

Inclisiran is an innovative medication used to lower LDL cholesterol levels. It is administered by injection just twice a year and belongs to the class of siRNA therapeutics.

What is Inclisiran?

Inclisiran is a novel, prescription-only medication used to treat elevated LDL cholesterol levels (hypercholesterolaemia) and mixed dyslipidaemia. It belongs to the class of small interfering RNA (siRNA) therapeutics and works at the molecular level within liver cells. Inclisiran is marketed under the brand name Leqvio® and has been approved by the European Medicines Agency (EMA) as well as other regulatory authorities.

Indications

Inclisiran is indicated for adults with:

  • Primary hypercholesterolaemia (heterozygous familial or non-familial) or mixed dyslipidaemia
  • Insufficient LDL cholesterol reduction despite maximally tolerated statin therapy
  • Statin intolerance or contraindications to statin use

It is used as an adjunct to a low-cholesterol diet and, where appropriate, in combination with other lipid-lowering therapies.

Mechanism of Action

Inclisiran uses RNA interference (RNAi) to inhibit the production of the enzyme PCSK9 (proprotein convertase subtilisin/kexin type 9) in the liver. PCSK9 is an enzyme that degrades LDL receptors, which are responsible for removing LDL cholesterol from the bloodstream.

By silencing PCSK9 production, more LDL receptors remain available on the surface of liver cells, allowing greater uptake and clearance of LDL cholesterol from the blood. This results in a significant reduction in LDL cholesterol levels of up to 50%.

Difference from PCSK9 Antibodies

Unlike monoclonal antibodies such as evolocumab or alirocumab, which block the PCSK9 protein in the bloodstream, inclisiran works upstream by preventing the synthesis of the PCSK9 protein inside liver cells. This mechanism allows for a longer duration of action and a much less frequent dosing schedule.

Dosage and Administration

Inclisiran is administered as a subcutaneous injection (under the skin). The dosing schedule is particularly convenient for patients:

  • First injection at the start of treatment
  • Second injection after 3 months
  • Subsequently, one injection every 6 months

The injection is administered by a healthcare professional, typically in a clinical setting. The dose is 284 mg of inclisiran (as inclisiran sodium).

Side Effects

Inclisiran is generally well tolerated. The most common side effects include:

  • Injection site reactions: redness, pain, swelling, or bruising (very common)
  • Bronchitis
  • Urinary tract infections
  • Joint pain (arthralgia)
  • Elevated liver enzyme levels (rare)

Serious adverse effects are uncommon. Inclisiran must not be used in patients with a known hypersensitivity to the active substance or any of the excipients.

Clinical Evidence

The clinical efficacy of inclisiran has been extensively evaluated in the ORION clinical trial programme. These large-scale Phase III studies demonstrated a sustained LDL cholesterol reduction of approximately 50% throughout the treatment period. Inclisiran is especially recommended for patients who fail to achieve their LDL target values despite statin therapy or who are unable to tolerate statins.

References

  1. European Medicines Agency (EMA): Leqvio (inclisiran) - Product information and approval documents. https://www.ema.europa.eu
  2. Ray KK et al. - Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol. New England Journal of Medicine, 2020; 382:1507-1519.
  3. Raal FJ et al. - Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolaemia. New England Journal of Medicine, 2020; 382:1520-1530.
artgerecht

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Verwandte Produkte

floral lactoferrin cln mundflora lutschtabletten?ts=1781276101

Average rating of 4.96 out of 5 stars

Floral

For Healthy Oral Flora & Dental Care

Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
Sugar free
Lab tested
Non-GMO
Cologne List
Lactose free
Tooth friendly
GMP Quality
Clinical proofed
Pure CLN
30 lozenges
Regular price: €22.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.
lactoferrin 60 eisenbinder transporter kuhmilch?ts=1758111262

Average rating of 4.85 out of 5 stars

Lactoferrin

For your universal protection

As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Lactose free
[siehe Varianten]
Regular price: €59.90
natural iron supplement premium plantderived mineralcomplex?ts=1751927698

Average rating of 4.94 out of 5 stars

Natural Iron

For your iron balance

Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Gluten free
Lactose free
100% vegetarian fermentation
30 Capsules
30 Capsules
Regular price: €35.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.